SABS

Open Orphan positive results from Influenza Human Challenge Study conducted by hVIVO

Open Orphan plc (LON:ORPH) a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has noted the announcement..

Search

Funds

SABS

Search

Funds

SABS

FTSE 100

Funds